Already we have people coming saying, ‘I want this blood test. I have a family history of Alzheimer’s disease.’” ...

A p-tau217 blood test predicted a 78% chance of cognitive decline within 10 years for symptom-free adults with very high ...

A real world study suggests found that more than three-quarters of participants receiving the anti-amyloid drug Leqembi ...

We’re at the early stages of having doctors understanding how to utilize these tests and how to move forward.” ...

In a new study, elevated blood biomarkers of Alzheimer's in healthy adults were tied to future cognitive risk. But the test ...

Study lead Dr. Angharad de Cates told Newsweek: "Our findings offer promise for addressing cognitive problems in depression." ...

The Center for Children and Families is examining how a video game designed to be therapeutic might help youngsters practice ...

Scientists suggested that simple blood tests that measure levels of the key biomarkers amyloid and tau can not only help ...

These Alzheimer's tests raise many important issues that patients and their physicians should carefully consider before ...

Researchers found that a blood test measuring the biomarker p-tau217 helped estimate the likelihood of developing cognitive impairment over the next five t ...

A blood test for the biomarker phosphorylated tau 217 (p-tau217) recently received federal clearance, but questions have ...

Research presented this week at the Alzheimer’s Association International Conference in London suggests that the use of blood ...